By Izzy Wood (Drug Target Review)2023-06-29T15:30:23
US researchers find that recurrent bouts of systemic lupus erythematosus is closely tracked with measurable upticks in growth in the gut of a certain species of bacteria.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2023-04-04T15:03:09
Sponsored by Agilent
2026-05-19T09:46:00
Contributor Dr Nitza Thomasson
2023-05-18T10:39:07
Sponsored by BPS Bioscience
2023-07-11T16:13:06
Sponsored by Agilent
2025-05-14T14:30:00
Sponsored by Abzena
Site powered by Webvision Cloud